ID

22059

Beskrivning

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00264472

Länk

https://clinicaltrials.gov/show/NCT00264472

Nyckelord

Versioner (1)
  1. 2017-05-17 2017-05-17 -
Uppladdad den

17 maj 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Neoplasms NCT00264472

Engelsk

Eligibility Neoplasms NCT00264472

1 Formulär  
  1. StudyEvent: Eligibility
    1. Eligibility Neoplasms NCT00264472
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed written informed consent
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
> or = 18 years of age
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
advanced or metastatic solid tumors:
Beskrivning

Solid tumour Advanced | Solid tumour metastatic

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
part 1: histologically proven advanced or metastatic solid tumors refractory to standard therapy or for which no standard therapy exists
Beskrivning

Solid tumour Advanced | Solid tumour metastatic | Standard therapy refractory | Standard therapy Unavailable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
UMLS CUI [3,1]
C2936643
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C2936643
UMLS CUI [4,2]
C0686905
part 2: histologically proven advanced and/or metastatic solid tumor of one of the following 6 histologies, that is refractory to standard curative therapy or for which no curative therapy exists: hcc, nsclc, gastric cancer, cervical cancer, prostate cancer, and breast cancer
Beskrivning

Solid tumour Advanced | Solid tumour metastatic | Curative treatment refractory | Curative treatment Unavailable | Liver carcinoma | Non-Small Cell Lung Carcinoma | Stomach Carcinoma | Cervix carcinoma | Prostate carcinoma | Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
UMLS CUI [3,1]
C1273390
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C1273390
UMLS CUI [4,2]
C0686905
UMLS CUI [5]
C2239176
UMLS CUI [6]
C0007131
UMLS CUI [7]
C0699791
UMLS CUI [8]
C0302592
UMLS CUI [9]
C0600139
UMLS CUI [10]
C0678222
radiologically documented measurable or evaluable (non-measurable) disease
Beskrivning

Measurable Disease | Evaluable Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
adequate performance status and organ function, as evidenced by hematologic and biochemical blood testing
Beskrivning

performance status | Organ function | Hematologic Test | Blood Test Biochemical

Datatyp

boolean

Alias
UMLS CUI [1]
C1518965
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0018941
UMLS CUI [4,1]
C0018941
UMLS CUI [4,2]
C0205474
willing to not receive fluoropyrimidine containing chemotherapy for 8 weeks after the last dose of adh300004 in this study
Beskrivning

Chemotherapy Containing Pyrimidine Unwilling | ADH300004

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0034284
UMLS CUI [1,4]
C0558080
UMLS CUI [2]
C1831604
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
cytotoxic chemotherapy, radiotherapy, or investigational drug within 28 days prior to study entry
Beskrivning

Cytotoxic Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0013230
non-cytotoxic cancer therapy within 14 days prior to study entry
Beskrivning

cancer treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0920425
portal hypertension with bleeding esophageal or gastric varices within the past 3 months
Beskrivning

Hypertension, Portal | Esophageal bleeding | Gastric Varix

Datatyp

boolean

Alias
UMLS CUI [1]
C0020541
UMLS CUI [2]
C0239293
UMLS CUI [3]
C0017145
ascites that is refractory to conservative management
Beskrivning

Ascites Conservative therapy refractory

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0003962
UMLS CUI [1,2]
C0459914
UMLS CUI [1,3]
C0205269
inability to take oral medication
Beskrivning

Able to swallow oral medication

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
active peptic ulcer disease
Beskrivning

Peptic Ulcer

Datatyp

boolean

Alias
UMLS CUI [1]
C0030920
known hypersensitivity to 5-fu or adh300004
Beskrivning

Hypersensitivity Fluorouracil | Hypersensitivity ADH300004

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016360
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1831604
stroke, major surgery, or other major tissue injury within 30 days before study entry
Beskrivning

Cerebrovascular accident | major surgery | Tissue injury Major

Datatyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0679637
UMLS CUI [3,1]
C2136639
UMLS CUI [3,2]
C0205164
Tillbaka till toppen

Similar models

Eligibility Neoplasms NCT00264472

1 Formulär
  1. StudyEvent: Eligibility
    1. Eligibility Neoplasms NCT00264472
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
> or = 18 years of age
boolean
C0001779 (UMLS CUI [1])
Solid tumour Advanced | Solid tumour metastatic
Item
advanced or metastatic solid tumors:
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
Solid tumour Advanced | Solid tumour metastatic | Standard therapy refractory | Standard therapy Unavailable
Item
part 1: histologically proven advanced or metastatic solid tumors refractory to standard therapy or for which no standard therapy exists
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0686905 (UMLS CUI [4,2])
Solid tumour Advanced | Solid tumour metastatic | Curative treatment refractory | Curative treatment Unavailable | Liver carcinoma | Non-Small Cell Lung Carcinoma | Stomach Carcinoma | Cervix carcinoma | Prostate carcinoma | Breast Carcinoma
Item
part 2: histologically proven advanced and/or metastatic solid tumor of one of the following 6 histologies, that is refractory to standard curative therapy or for which no curative therapy exists: hcc, nsclc, gastric cancer, cervical cancer, prostate cancer, and breast cancer
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C1273390 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4,1])
C0686905 (UMLS CUI [4,2])
C2239176 (UMLS CUI [5])
C0007131 (UMLS CUI [6])
C0699791 (UMLS CUI [7])
C0302592 (UMLS CUI [8])
C0600139 (UMLS CUI [9])
C0678222 (UMLS CUI [10])
Measurable Disease | Evaluable Disease
Item
radiologically documented measurable or evaluable (non-measurable) disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
performance status | Organ function | Hematologic Test | Blood Test Biochemical
Item
adequate performance status and organ function, as evidenced by hematologic and biochemical blood testing
boolean
C1518965 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
C0018941 (UMLS CUI [3])
C0018941 (UMLS CUI [4,1])
C0205474 (UMLS CUI [4,2])
Chemotherapy Containing Pyrimidine Unwilling | ADH300004
Item
willing to not receive fluoropyrimidine containing chemotherapy for 8 weeks after the last dose of adh300004 in this study
boolean
C0392920 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0034284 (UMLS CUI [1,3])
C0558080 (UMLS CUI [1,4])
C1831604 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs
Item
cytotoxic chemotherapy, radiotherapy, or investigational drug within 28 days prior to study entry
boolean
C0677881 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
cancer treatment
Item
non-cytotoxic cancer therapy within 14 days prior to study entry
boolean
C0920425 (UMLS CUI [1])
Hypertension, Portal | Esophageal bleeding | Gastric Varix
Item
portal hypertension with bleeding esophageal or gastric varices within the past 3 months
boolean
C0020541 (UMLS CUI [1])
C0239293 (UMLS CUI [2])
C0017145 (UMLS CUI [3])
Ascites Conservative therapy refractory
Item
ascites that is refractory to conservative management
boolean
C0003962 (UMLS CUI [1,1])
C0459914 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Able to swallow oral medication
Item
inability to take oral medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Peptic Ulcer
Item
active peptic ulcer disease
boolean
C0030920 (UMLS CUI [1])
Hypersensitivity Fluorouracil | Hypersensitivity ADH300004
Item
known hypersensitivity to 5-fu or adh300004
boolean
C0020517 (UMLS CUI [1,1])
C0016360 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1831604 (UMLS CUI [2,2])
Cerebrovascular accident | major surgery | Tissue injury Major
Item
stroke, major surgery, or other major tissue injury within 30 days before study entry
boolean
C0038454 (UMLS CUI [1])
C0679637 (UMLS CUI [2])
C2136639 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial